Median Technologies (Group)

https://www.mediantechnologies.com

MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice. MEDIAN Technologies standardizes and automates the interpretation of medical images in oncology to optimize the diagnosis of cancer patients and the assessment of their response to therapy. MEDIAN serves two primary markets: drug development and patient care. MEDIAN has a strategic partnership with the world's largest CRO (Contract Research Organization) to offer integrated imaging services for clinical trials to biopharma sponsors worldwide, and a strategic partnership with Canon to develop new imaging technologies, and to address the patient care market. Founded in 2002, MEDIAN Technologies is based in Sophia-Antipolis, France, and has a US subsidiary in Boston. MEDIAN has a global reach and actively works with clinical sites located in Asia, Europe, North and South America, and Australia. MEDIAN has received the label "Innovative company" by the BPI and is listed on Euronext Paris' Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA PME SME equity savings plan setup. *

	Start	2002-01-01 established
	Industry	image analysis software
	Industry 2	imaging technology (diagnostics)
	Person	Brag, Fredrik (Median Technologies 201408 CEO)

	Region	Valbonne
	Country	France
	Street	1800 route des Crêtes
	City	06560 Valbonne – Sophia Antiplis
	Tel	+33-4-9333-3777
		Address record changed: 2024-01-05

Basic data	Employees	D: 101 to 500 (2021-12-31)
	Currency	EUR
	Annual sales	14,120,000 (revenues, annual, consolidated (2021) 2021-12-31)
	Profit	-11,994,000 (2021-12-31)
	Cash	36,160,000 (2021-12-31)

		* Document for »About Section«:

		Record changed: 2024-02-12

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for Median Technologies (Group)

[1] Median Technologies S.A.. (12/14/23). "Press Release: Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine". Sophia Antipolis & Saclay....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]